Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Diakron Pharmaceutical Inc.
DescriptionOral direct thrombin inhibitor (DTI)
Molecular Target Thrombin (Factor IIa) (F2)
Mechanism of ActionThrombin inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationThrombosis
Indication DetailsTreat thrombosis
Regulatory Designation
PartnerOrchid Chemicals & Pharmaceuticals Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today